Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger B Cohen

Showing results (91-100 of 208) with videos related to

Pageof 21
Sort By:
Cancer Chemotherapy and Pharmacology|October 13, 2006
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)Roger B Cohen, Corey J Langer, George Rajan Simon, et al.
Clinical Lung Cancer|July 14, 2023
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimensWilliam P Tompkins, Wei-Ting Hwang, Yu-Xiao Yang, et al.
Clinical Lung Cancer|November 20, 2016
Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung CancerStephen J Bagley, Steven Vitale, Suhong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinomaHoward A Burris, Lee S Rosen, Caio M Rocha-Lima, et al.
Clinical Lung Cancer|November 21, 2017
The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung CancerAparna H Kesarwala, Diana J Lu, Eric Xanthopoulos, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2015
Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival OutcomesSurbhi Grover, Samuel Swisher-McClure, Nandita Mitra, et al.
Cancer|July 6, 2017
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancerJean-Claude M Rwigema, Vivek Verma, Liyong Lin, et al.
American Journal of Clinical Oncology|November 11, 2010
Increased recurrences using intensity-modulated radiation therapy in the postoperative settingAruna Turaka, Tianyu Li, Navesh K Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximabDesmond Curran, Jordi Giralt, Paul M Harari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid TumorsLaura W Goff, Roger B Cohen, Jordan D Berlin, et al.
Pageof 21

Showing results (91-100 of 208) with videos related to

Sort By:
Pageof 21
Cancer Chemotherapy and Pharmacology|October 13, 2006
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)Roger B Cohen, Corey J Langer, George Rajan Simon, et al.
Clinical Lung Cancer|July 14, 2023
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimensWilliam P Tompkins, Wei-Ting Hwang, Yu-Xiao Yang, et al.
Clinical Lung Cancer|November 20, 2016
Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung CancerStephen J Bagley, Steven Vitale, Suhong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinomaHoward A Burris, Lee S Rosen, Caio M Rocha-Lima, et al.
Clinical Lung Cancer|November 21, 2017
The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung CancerAparna H Kesarwala, Diana J Lu, Eric Xanthopoulos, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2015
Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival OutcomesSurbhi Grover, Samuel Swisher-McClure, Nandita Mitra, et al.
Cancer|July 6, 2017
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancerJean-Claude M Rwigema, Vivek Verma, Liyong Lin, et al.
American Journal of Clinical Oncology|November 11, 2010
Increased recurrences using intensity-modulated radiation therapy in the postoperative settingAruna Turaka, Tianyu Li, Navesh K Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximabDesmond Curran, Jordi Giralt, Paul M Harari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid TumorsLaura W Goff, Roger B Cohen, Jordan D Berlin, et al.
Pageof 21